GROUP ONE TRADING, L.P. - SUMMIT THERAPEUTICS INC ownership

SUMMIT THERAPEUTICS INC's ticker is and the CUSIP is 86627T908. A total of 4 filers reported holding SUMMIT THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of SUMMIT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$885,632
+838.4%
473,600
+1159.6%
0.00%
Q2 2023$94,376
-88.3%
37,600
-91.9%
0.00%
-100.0%
Q1 2023$808,150
-25.9%
461,800
+80.0%
0.00%0.0%
Q4 2022$1,090,550
+2769.9%
256,600
+709.5%
0.00%
Q3 2022$38,000
+3700.0%
31,700
+2164.3%
0.00%
Q2 2022$1,0000.0%1,400
+366.7%
0.00%
Q1 2022$1,000
-97.0%
300
-97.6%
0.00%
Q4 2021$33,000
-81.8%
12,400
-65.7%
0.00%
Q3 2021$181,000
+30.2%
36,200
+94.6%
0.00%
Q2 2021$139,000
+2680.0%
18,600
+1966.7%
0.00%
Q1 2021$5,0009000.00%
Other shareholders
SUMMIT THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 461,800$808,1500.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
SIMPLEX TRADING, LLC 23,100$400.00%
JANE STREET GROUP, LLC 46,000$80,5000.00%
View complete list of SUMMIT THERAPEUTICS INC shareholders